PPARG and chondrosarcoma: Activating peroxisome proliferator-activated receptor gamma (PPARγ) in chondrosarcoma cells—either directly or with drugs like zaltoprofen—has been shown to inhibit cell proliferation, induce apoptosis, and reduce invasion, marking it as a viable therapeutic pathway.